Fast Take Shenzhen New Industries Biomedical

研报英文原文证据摘录

Fast Take Shenzhen New Industries Biomedical

UBS AG, or any of its subsidiaries or branches. UBS

Switzerland AG is a public company limited by shares, incorporated in Switzerland with its registered offices at Bahnhofstrasse 45, CH-8001 Zurich. UBS Saudi Arabia (a

subsidiary of UBS AG) is a Saudi closed joint stock company incorporated in the Kingdom of Saudi Arabia with a paid capital of 110,000,000 Saudi Riyals under commercial

register number 1010257812 having its registered office at Laysen Valley, P.O. Box 75724, Riyadh 11588, Kingdom of Saudi Arabia. UBS Saudi Arabia is authorized and

regulated by the Capital Market Authority to conduct securities business under license number 08113-37. This document is distributed only under such circumstances as may

be permitted by applicable laws and regulations. The information and – if any - opinions contained in this document have been compiled or arrived at based upon

information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the

securities, markets or developments referred to in the document. All such information and opinions are subject to changes without notice. Past performance of investments

(whether simulated or actual) is not necessarily an indicator of future results. Forward looking data is based on estimates that are subject to changes. Should the currency of

a financial product or service not match your reference currency, performance may rise or fall due to currency fluctuations. UBS Switzerland AG and / or other members of the

UBS Group may have a position in and may make a purchase and/or sale of any of the securities or other financial instruments mentioned in this document While statements